<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Allogeneic BMT for severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> is associated with a significant rate of graft rejection, especially in patients who have been previously transfused </plain></SENT>
<SENT sid="1" pm="."><plain>We report a child with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> who rejected donor marrow twice despite adequate immunosuppression as part of the conditioning therapy but engrafted successfully following combined administration of three modalities of immunosuppression: antithymocyte globulin, total lymphoid irradiation and the monoclonal antibody Campath-1G </plain></SENT>
<SENT sid="2" pm="."><plain>Restriction fragment length polymorphism studies &gt; 1 year after BMT show full donor hematopoiesis with no evidence of autologous recovery </plain></SENT>
</text></document>